What is ADH?
ADH (antidiuretic hormone), also known as arginine vasopressin (AVP), is a nonapeptide hormone produced by neurons in the supraoptic and paraventricular nuclei of the hypothalamus, stored and released from the posterior pituitary gland, that acts primarily on the kidneys to promote water reabsorption and concentrate urine. 1, 2, 3
Anatomical Origin and Production
ADH is synthesized by large neurons originating in the hypothalamus that project through the pituitary stalk and terminate on capillary plexuses in the posterior pituitary 3. These capillaries drain into the systemic circulation via the cavernous sinus and superior vena cava, allowing the hormone to reach its target organs 3.
Primary Physiological Function
The main role of ADH is maintaining water homeostasis in the body through its antidiuretic actions 4. When ADH is released into the bloodstream, it acts on the kidneys to reduce water excretion and concentrate urine 1, 2. Without ADH influence (as seen in diabetes insipidus), a person would need to drink 5-15 liters of water daily to match urinary losses 5.
Mechanism of Action
ADH exerts its effects through three receptor subtypes 6:
V2 receptors (renal): Located in the kidney collecting ducts, these are responsible for the antidiuretic effect. V2 receptor activation stimulates cyclic AMP formation and phosphorylation of aquaporin-2 (AQP2) water channels, increasing their insertion into the apical membrane of collecting duct cells 4, 7. This dramatically increases water permeability and allows water reabsorption back into the bloodstream.
V1a receptors (vascular): Found in blood vessels, these mediate vasoconstriction and help maintain blood pressure 8, 4.
V1b receptors (pituitary): Located in the anterior pituitary, these participate in ACTH secretion 6.
Regulation of ADH Release
ADH secretion is primarily regulated by 6:
- Plasma osmolality (primary stimulus): Hypothalamic osmoreceptors detect increases in blood concentration and trigger ADH release
- Blood volume and pressure (secondary stimulus): Decreased blood volume or pressure stimulates ADH secretion
- Stress and other non-osmotic factors
Clinical Significance
ADH Deficiency (Diabetes Insipidus)
When ADH secretion is insufficient (central diabetes insipidus) or the kidneys cannot respond to it (nephrogenic diabetes insipidus), patients develop polyuria (excessive urination), polydipsia (excessive thirst), and risk hypertonic dehydration 1, 2, 9. The prevalence of medically treated diabetes insipidus is 7-10 patients per 100,000 inhabitants 2.
ADH Excess (SIADH)
Excessive or inappropriate ADH secretion causes water retention, leading to hyponatremia (low blood sodium) 10, 11. This syndrome of inappropriate antidiuresis (SIAD) affects more than 15% of hospitalized patients and is the most frequent cause of hypotonic hyponatremia 11. Common causes include malignancy (especially small-cell lung cancer), medications, pulmonary pathology, and central nervous system disorders 10, 6.
Therapeutic Applications
DDAVP (desmopressin), a synthetic analog of ADH, is the primary treatment for central diabetes insipidus 2. It acts predominantly on V2 receptors with minimal vasopressor activity 2. DDAVP can be administered subcutaneously, orally, intranasally, or sublingually, with dosing individualized based on patient response 2. The goal is to use the lowest dose that allows adequate nighttime rest and minimal disruption of daytime activities 2.